Amarbir Bhullar, MD
Cardiac Electrophysiology · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 14 years
- Graduated 2012
Offices
4 locations · Fresno Community Hospital and Medical Center · California Heart Medical Associates, Inc
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhullar’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$51,685
Medicare paid this office $51,685 for 196 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 13 | $8,904 | $685 |
| Return visit (30+ min) | 47 | $7,378 | $104 |
| New patient visit (45+ min) | 35 | $4,708 | $135 |
| New patient visit (60+ min) | 18 | $3,187 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,435 | $128 |
See all 13 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 13 | $8,904 | $685 |
| Return visit (30+ min) | 47 | $7,378 | $104 |
| New patient visit (45+ min) | 35 | $4,708 | $135 |
| New patient visit (60+ min) | 18 | $3,187 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,435 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $893 | $12 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $674 | $52 |
| Return visit (30+ min) | 22 | $571 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 51 | $278 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $139 | $9 |
| Ultrasonic guidance for blood vessel access | 13 | $139 | $11 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $134 | $8 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $114 | $7 |
Procedures Medicare counted
| Pacemaker insertion or repair | 25 | More than 75% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Insertion of pacemaker and upper and lower heart chamber electrode | – | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
196 Original Medicare patients in 2024. Average age 75 · Women 40% · Also on Medicaid 39% · Health risk score 1.91. Above the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 61% · Coronary heart disease 52% · Heart failure 51% · Diabetes 47% · Chronic kidney disease 44% · COPD 32% · Depression 24% · Cancer 15% · Stroke 11% · Dementia 9%.
The office billed $167,661, Medicare allowed $68,755 and paid $51,685; for 532 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 196 | 532 | 75 | 1.91 | $167,661 | $51,685 |
| 2023 | 824 | 1,846 | 75 | 2.01 | $286,790 | $79,941 |
| 2022 | 309 | 612 | 75 | 1.65 | $96,374 | $30,464 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 104 | $11,361 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 193 | $6,905 | $21 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $6,491 | $127 |
| New patient visit (45+ min) | 54 | $5,207 | $96 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,601 | $383 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,187 | $59 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 96 | $3,960 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 441 | $3,326 | $6 |
| Programming of dual lead pacemaker system | 63 | $2,161 | $26 |
| Short return visit (20+ min) | 30 | $1,488 | $48 |
| Programming of multiple lead implantable defibrillator system | 21 | $915 | $38 |
| New patient visit (30+ min) | 12 | $747 | $62 |
| Programming of single lead implantable defibrillator system | 12 | $377 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 20 | $358 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $160 | $9 |
2022: 10 services
| Return visit (30+ min) | 42 | $4,447 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,415 | $148 |
| New patient visit (45+ min) | 20 | $2,000 | $100 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 63 | $1,712 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,306 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,282 | $53 |
| Short return visit (20+ min) | 20 | $1,060 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $989 | $28 |
| Programming of dual lead pacemaker system | 16 | $548 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 19 | $326 | $17 |
Medicaid work
$46 in 2024
Medicaid paid $46 for 70 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 27 | $46 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 17 | $0 |
| Return visit (30+ min) | 26 | $0 |
| 2024 | 70 | 3 | 17 | $46 |
| 2023 | 1,017 | 5 | 135 | $8,930 |
| 2022 | 235 | 2 | 78 | $1,846 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 821 | $5,231 |
| Return visit (30+ min) | 81 | $2,142 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 44 | $943 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 55 | $438 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 16 | $176 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 221 | $1,292 |
| New patient visit (30+ min) | 14 | $554 |
Drugs they prescribed that Part D paid
$112,310
Pharmacies billed $112,310 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 390) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
282 generic and 108 brand-name prescriptions · $112,310 in drug cost · 11 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 80 | $80,869 | $1,011 |
| Xarelto | 13 | $10,209 | $785 |
| Metoprolol | 70 | $1,113 | $16 |
| Flecainide Acetate | 28 | $628 | $22 |
| Carvedilol | 25 | $255 | $10 |
See all 9 drugs
| Eliquis | 80 | $80,869 | $1,011 |
| Xarelto | 13 | $10,209 | $785 |
| Metoprolol | 70 | $1,113 | $16 |
| Flecainide Acetate | 28 | $628 | $22 |
| Carvedilol | 25 | $255 | $10 |
| Atorvastatin | 16 | $187 | $12 |
| Amiodarone | 12 | $160 | $13 |
| Clopidogrel | 15 | $118 | $8 |
| Metoprolol | 19 | $67 | $4 |
Year by year
| 2024 | 390 | 163 | 0% (0) | 28% | $112,310 |
| 2023 | 752 | 199 | 0% (0) | 22% | $171,408 |
| 2022 | 163 | 64 | 0% (0) | 14% | $19,768 |
| 2021 | 24 | None | 0% (0) | None | $1,826 |
| 2017 | 14 | None | 0% (0) | None | $109 |
| 2016 | 11 | None | 0% (0) | 0% | $95 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Eliquis | 125 | $119,680 | $957 |
| Xarelto | 11 | $15,353 | $1,396 |
| Entresto | 13 | $13,231 | $1,018 |
| Metoprolol | 141 | $2,576 | $18 |
| Flecainide Acetate | 56 | $2,542 | $45 |
| Amiodarone | 49 | $910 | $19 |
| Sotalol | 14 | $591 | $42 |
| Carvedilol | 27 | $421 | $16 |
| Diltiazem 24hr Er (Cd) | 18 | $384 | $21 |
| Atorvastatin | 25 | $278 | $11 |
| Clopidogrel | 19 | $239 | $13 |
| Metoprolol | 31 | $204 | $7 |
| Lisinopril | 28 | $172 | $6 |
| Cephalexin | 21 | $128 | $6 |
| Warfarin | 12 | $93 | $8 |
| Amlodipine Besylate | 13 | $72 | $6 |
| Furosemide | 15 | $38 | $3 |
2022: 4 drugs
| Eliquis | 18 | $12,435 | $691 |
| Flecainide Acetate | 17 | $565 | $33 |
| Metoprolol | 45 | $541 | $12 |
| Amiodarone | 13 | $257 | $20 |
2021: 1 drug
| Metoprolol | 11 | $234 | $21 |
Money from drug and device companies
$2,709 in 2025
| 2025 | 17 | 100 | None | $2,709 |
| 2024 | 19 | 89 | None | $6,270 |
| 2023 | 16 | 38 | None | $881 |
| 2022 | 13 | 51 | None | $6,889 |
| 2021 | 5 | 25 | None | $7,260 |
| 2020 | 4 | 6 | None | $9,096 |
| 2019 | 4 | 10 | None | $310 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Micra | $419 | 6 payments
|
| Amgen | Repatha | $418 | 27 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $210 | 5 payments
|
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $204 | 13 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $192 | 9 payments
|
| Abbott Laboratories | Perclose Prostyle | $172 | 8 payments
|
See all 100 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-22 | Lifevest | $12 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-22 | Kerendia | $29 |
| Amgen | Meals · 2025-12-22 | Repatha | $11 |
| Abbott Laboratories | Meals · 2025-12-19 | Agilis | $28 |
| Boston Scientific | Meals · 2025-12-15 | Watchman Flx | $29 |
| Alnylam Pharmaceuticals | Meals · 2025-12-08 | Amvuttra | $20 |
| Amgen | Meals · 2025-12-04 | Repatha | $8 |
| GlaxoSmithKline | Meals · 2025-11-25 | Shingrix | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-21 | Kerendia | $125 |
| Amgen | Meals · 2025-11-18 | Repatha | $16 |
| Boston Scientific | Meals · 2025-11-14 | Accolade Sr | $32 |
| Abbott Laboratories | Meals · 2025-11-13 | Perclose Prostyle | $21 |
| Amgen | Meals · 2025-11-12 | Repatha | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-10 | Lifevest | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-10 | Jardiance | $23 |
| Boston Scientific | Meals · 2025-11-04 | Rhythmia Mapping System | $3 |
| Amgen | Meals · 2025-10-31 | Repatha | $9 |
| Merck Sharp & Dohme | Meals · 2025-10-22 | Capvaxive | $14 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Leqvio | $23 |
| Amgen | Meals · 2025-10-14 | Repatha | $6 |
| Abiomed | Meals · 2025-10-13 | None | $25 |
| Amgen | Meals · 2025-10-09 | Repatha | $2 |
| Abbott Laboratories | Meals · 2025-10-09 | Mitraclip | $18 |
| Abbott Laboratories | Meals · 2025-10-07 | Accent | $23 |
| Alnylam Pharmaceuticals | Meals · 2025-10-06 | Amvuttra | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-03 | Jardiance | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-02 | Lifevest | $21 |
| Biosense Webster | Meals · 2025-09-30 | Nuvision Ice Catheter | $141 |
| Abbott Laboratories | Education · 2025-09-25 | Perclose Prostyle | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-17 | Jardiance | $125 |
| Medtronic | Meals · 2025-09-12 | Azure Xt Dr Mri Surescan | $99 |
| Merck Sharp & Dohme | Meals · 2025-09-12 | Verquvo | $30 |
| Abbott Laboratories | Meals · 2025-09-08 | Perclose Prostyle | $16 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Leqvio | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-28 | Lifevest | $20 |
| Alnylam Pharmaceuticals | Meals · 2025-08-26 | Amvuttra | $24 |
| GlaxoSmithKline | Meals · 2025-08-25 | Shingrix | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-20 | Kerendia | $8 |
| Amgen | Meals · 2025-08-20 | Repatha | $15 |
| Cardiva Medical | Meals · 2025-08-14 | Cardiva Vascade Mvp Vvcs 6-12f | $8 |
| Amgen | Meals · 2025-08-13 | Repatha | $14 |
| Novartis Pharmaceuticals | Meals · 2025-08-08 | Leqvio | $22 |
| Amgen | Meals · 2025-07-29 | Repatha | $7 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-23 | Lifevest | $18 |
| Alnylam Pharmaceuticals | Meals · 2025-07-18 | Amvuttra | $24 |
| Amgen | Meals · 2025-07-18 | Repatha | $10 |
| Cardiva Medical | Meals · 2025-07-09 | Cardiva Vascade 6/7f Vcs | $25 |
| Abbott Laboratories | Meals · 2025-07-01 | Perclose Prostyle | $19 |
| Amgen | Meals · 2025-06-27 | Repatha | $17 |
| Amgen | Meals · 2025-06-16 | Repatha | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-13 | Jardiance | $19 |
| Novartis Pharmaceuticals | Meals · 2025-06-12 | Leqvio | $18 |
| Cardiva Medical | Meals · 2025-06-06 | Cardiva Vascade 6/7f Vcs | $8 |
| Medtronic | Meals · 2025-06-04 | Selectsecure | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-03 | Lifevest | $23 |
| Abiomed | Meals · 2025-05-28 | None | $27 |
| Amgen | Meals · 2025-05-27 | Repatha | $11 |
| Amgen | Meals · 2025-05-22 | Repatha | $4 |
| Alnylam Pharmaceuticals | Meals · 2025-05-17 | Amvuttra | $24 |
| Cardiva Medical | Meals · 2025-05-16 | Cardiva Vascade Mvp Vvcs 6-12f | $27 |
| Actelion Pharmaceuticals US | Meals · 2025-05-15 | Uptravi | $16 |
| Amgen | Meals · 2025-05-15 | Repatha | $8 |
| Merck Sharp & Dohme | Meals · 2025-05-14 | Verquvo | $23 |
| Cardiva Medical | Meals · 2025-05-09 | Cardiva Vascade 6/7f Vcs | $34 |
| Amgen | Meals · 2025-05-05 | Repatha | $17 |
| Medtronic | Meals · 2025-04-27 | Micra | $17 |
| Medtronic | Meals · 2025-04-26 | Cobalt Dr Mri Surescan | $93 |
| Medtronic | Meals · 2025-04-26 | Cobalt Dr Mri Surescan | $19 |
| Medtronic | Meals · 2025-04-25 | Micra | $174 |
| Merck Sharp & Dohme | Meals · 2025-04-25 | Verquvo | $24 |
| Biotronik | Meals · 2025-04-25 | Biomonitor | $136 |
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
| Amgen | Meals · 2025-04-18 | Repatha | $9 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-04-10 | Lifevest | $31 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-07 | Jardiance | $20 |
| Amgen | Meals · 2025-03-27 | Repatha | $11 |
| Merck Sharp & Dohme | Meals · 2025-03-26 | Verquvo | $26 |
| Pfizer | Meals · 2025-03-20 | Vyndaqel | $20 |
| Cardiva Medical | Meals · 2025-03-14 | Cardiva Vascade 6/7f Vcs | $27 |
| Amgen | Meals · 2025-03-14 | Repatha | $21 |
| Amgen | Meals · 2025-03-12 | Repatha | $5 |
| Cardiva Medical | Meals · 2025-03-06 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $8 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-26 | Lifevest | $25 |
| Amgen | Meals · 2025-02-25 | Repatha | $12 |
| Cardiva Medical | Meals · 2025-02-20 | Cardiva Vascade Mvp Vvcs 6-12f | $7 |
| Alnylam Pharmaceuticals | Meals · 2025-02-19 | Amvuttra | $24 |
| Amgen | Meals · 2025-02-14 | Repatha | $5 |
| Amgen | Meals · 2025-02-12 | Repatha | $10 |
| Amgen | Meals · 2025-02-12 | Repatha | $125 |
| Cardiva Medical | Meals · 2025-02-11 | Cardiva Vascade Mvp Vvcs 6-12f | $26 |
| Amgen | Meals · 2025-02-05 | Repatha | $12 |
| Actelion Pharmaceuticals US | Meals · 2025-01-29 | Uptravi | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-28 | Lifevest | $21 |
| Amgen | Meals · 2025-01-24 | Repatha | $16 |
| Cardiva Medical | Meals · 2025-01-23 | Cardiva Vascade Mvp Vvcs 6-12f | $8 |
| Actelion Pharmaceuticals US | Meals · 2025-01-14 | Opsumit | $28 |
| Cardiva Medical | Meals · 2025-01-10 | Cardiva Vascade Mvp Vvcs 6-12f | $8 |
| Abbott Laboratories | Meals · 2025-01-10 | Aveir | $30 |
| Cardiva Medical | Meals · 2025-01-08 | Cardiva Vascade Mvp Vvcs 6-12f | $9 |
| Cardiva Medical | Meals · 2025-01-02 | Cardiva Vascade 6/7f Vcs | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,270
| Biotronik | Amvia Edge | $2,437 | 5 payments
|
| Philips North America | (9520) Igt Devices Undivided | $1,109 | 8 payments
|
| Amgen | Repatha | $902 | 29 payments
|
| Medtronic | Micra | $430 | 3 payments
|
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $289 | 13 payments
|
| Biosense Webster | Qdot Micro Catheter | $267 | 2 payments
|
| Lexicon Pharmaceuticals | Inpefa | $188 | 4 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $139 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $95 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $91 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $58 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $52 | 3 payments
|
| Cordis US | Mynx Venous Vcd | $46 | 1 payment
|
| Boston Scientific | Watchman Flx | $45 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $43 | 2 payments
|
| Abbott Laboratories | Assurity | $22 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $20 | 1 payment
|
| Pfizer | Prevnar 20 | $19 | 1 payment
|
| Daiichi Sankyo | Injectafer | $17 | 1 payment
|
2023: $881
| Abbott Laboratories | Ensite | $205 | 5 payments
|
| Actelion Pharmaceuticals US | Uptravi | $108 | 4 payments
|
| Medtronic | Micra | $84 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $67 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $64 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $52 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $50 | 3 payments
|
| Pfizer | Eliquis | $47 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $40 | 2 payments
|
| Amgen | Repatha | $40 | 2 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $33 | 1 payment
|
| CVRx | Barostim Neo System | $23 | 2 payments
|
| Chiesi USA | Kengreal | $18 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $18 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $18 | 1 payment
|
| Philips Electronics North America | (9124) Lm Undivided | $14 | 1 payment
|
2022: $6,889
| Abbott Laboratories | Ensite Precision | $3,745 | 27 payments
|
| Biotronik | Biomonitor | $2,456 | 8 payments
|
| Medtronic | Micra | $205 | 3 payments
|
| Boston Scientific | Versacross Large Access Solution | $156 | 3 payments
|
| Biosense Webster | Carto 3 | $101 | 1 payment
|
| Philips Electronics North America | (9124) Lm Undivided | $82 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $31 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $24 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $23 | 1 payment
|
| Chiesi USA | Kengreal | $19 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $19 | 1 payment
|
| Amgen | Repatha | $15 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $13 | 1 payment
|
2021: $7,260
| Boston Scientific | Emblem S Icd Electrode Delivery System | $4,006 | 6 payments
|
| Medtronic | Micra | $2,828 | 14 payments
|
| Biotronik | Rivacor | $380 | 3 payments
|
| Philips Electronics North America | (9272) Glidelight | $32 | 1 payment
|
| Baylis Medical Company | Versacross Access Solution | $14 | 1 payment
|
2020: $9,096
| Medtronic Vascular | None | $5,000 | 1 payment
|
| Boston Scientific | General - Brady | $3,845 | 2 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $234 | 2 payments
|
| Chiesi USA | Kengreal 50mg/10ml L | $17 | 1 payment
|
2019: $310
| United Therapeutics | Remodulin | $116 | 3 payments
|
| Amgen | Repatha | $107 | 4 payments
|
| Medtronic Vascular | Micra | $68 | 2 payments
|
| Sanofi-Aventis U.S. | Sotagliflozin | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1790199453
- Licence
- KY 56378
- Group
- Fresno Community Hospital and Medical Center · California Heart Medical Associates, Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Student in a training program (390200000X)
- Mailing address
- Po Box 2379, Ashland, KY, 41105
- NPI first listed
- 2014-06-19
- NPI last updated
- 2022-07-22
- NPI record certified
- 2022-07-22
This is when the NPI record was last certified, not a medical board exam.